US 12109236
Manipulating ARID5B expression in immune cells to promote metabolism, survival, and function
granted A61KA61K35/17A61K40/11
Quick answer
US patent 12109236 (Manipulating ARID5B expression in immune cells to promote metabolism, survival, and function) held by Regents of the University of Minnesota expires Mon Oct 03 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Regents of the University of Minnesota
- Grant date
- Tue Oct 08 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 03 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K35/17, A61K40/11, A61K40/15, A61K40/46